Get the app
US › Healthcare

Artelo Biosciences Inc (ARTL)

US · Healthcare · Biotechnology

$2.70-1.46%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-2.4M
EPS
$-0.89

Key statistics

Market cap
$1.8M
Forward P/E
0.0
P/B
0.80
Book value
$10.74
EPS (TTM)
$-136.26
52-week high
$130.33
52-week low
$3.19
50-day MA
$5.59
200-day MA
$24.65
Beta
-0.07

Analyst view

with an average price target of $18.00.

Shareholding

Insiders
0.11%
Institutions
2.38%

Largest institutional holders

FundStake
Jane Street Group LLC1.35%
Geode Capital Management, LLC0.28%
StoneX Group Inc0.25%
Vanguard Capital Management, LLC0.21%
Tower Research Capital LLC0.17%
Vanguard Fiduciary Trust Co0.06%
UBS Group AG0.06%
TD Waterhouse Canada Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Artelo Biosciences Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.